Abstract:Molecularly targeted therapies are at the forefront of clinical science, and are expected to lead to personalization of medical treatments for each patient. Most such therapies are directed at inhibiting specific signal transduction enzymes or pathways, thus creating a critical need for assays capable of measuring the activities of these proteins in disease models and in patient samples. The ability to measure relevant enzyme activity in primary cell samples at baseline and/or after treatment would provide the ability to tailor patient therapy based on aberrant signal transduction, validate mechanisms of resistance in patients, and would offer an invaluable pharmacodynamic tool to assess whether resistance is associated with inadequate target inhibition. Here we report our current efforts to create the analytical and chemical tools needed to directly measure the enzymatic activities of therapeutic targets including protein kinases, lipid modifying enzymes and the proteasome. Fluorescent reagents are under development that report the activity of these various enzymes in model cells lines and primary cells. The basic design incorporates enzyme substrates that are modified to create compounds which can be loaded into cells where they are modified by the enzyme of interest. Work has included modification of peptides to confer membrane permeability and to achieve long intracellular lifetimes. Microelectrophoretic separations combined with low-level fluorescence detection enable the quantitative analysis of these compounds from single mammalian cells. This capability addresses three major issues currently faced in the biochemical analysis of clinical samples: the need for direct measurement of the enzymatic activity of target proteins; sample size requirements that are feasible for clinical implementation; and sample heterogeneity that can mask pertinent aspects related to therapeutic response.

Real-time measurement of small molecules directly in awake, ambulatory animals

Real-Time, In Vivo Molecular Monitoring Using Electrochemical Aptamer Based Sensors: Opportunities and Challenges

Microdialysis Coupled with Droplet Microfluidics and Mass Spectrometry for Determination of Neurotransmitters in vivo with High Temporal Resolution

Selected Recent in Vivo Studies on Chemical Measurements in Invertebrates

Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

(Keynote) Enabling Continuous Molecular Monitoring in vivo via Implantable and Wearable Aptamer-Based Sensors

In-Depth Chemical Analysis of the Brain Extracellular Space Using In Vivo Microdialysis with Liquid Chromatography-Tandem Mass Spectrometry

Real-Time NMR Spectroscopy for Studying Metabolism

Genetically Encoded Sensors for the in Vivo Detection of Neurochemical Dynamics.

A high‐precision view of intercompartmental drug transport via simultaneous, seconds‐resolved, in situ measurements in the vein and brain

Real-Time Tunable Dynamic Range for Calibration-Free Biomolecular Measurements with a Temperature-Modulated Electrochemical Aptamer-Based Sensor in an Unprocessed Actual Sample

Real-time selective detection of dopamine and serotonin at nanomolar concentration from complex in vitro systems

Dynamic single-molecule sensing by actively tuning binding kinetics for ultrasensitive biomarker detection

An Electrochemical Biosensor Architecture Based on Protein Folding Supports Direct Real‐Time Measurements in Whole Blood

A neural probe for concurrent real-time measurement of multiple neurochemicals with electrophysiology in multiple brain regions in vivo

Dual-Frequency, Ratiometric Approaches to EAB Sensor Interrogation Support the Calibration-Free Measurement of Specific Molecules In Vivo

A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals

Integrative Wireless Device for Remote Continuous Blood Biomarker Monitoring

Wireless Neurochemical Monitoring in Humans

Single-Cell Biochemical Assays For The Molecular Targets Of Disease

In-situ real-time monitoring of chemical kinetics by an automated micro-reaction device